Justin P. Kline to Lymphoma, T-Cell, Peripheral
This is a "connection" page, showing publications Justin P. Kline has written about Lymphoma, T-Cell, Peripheral.
Connection Strength
0.110
-
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas. Br J Haematol. 2013 Oct; 163(1):55-61.
Score: 0.110